FONDAPARINUX Side Effects

6426834-X | Thrombocytopenia
on Nov 03, 2009 Male patient from UNITED STATES , 87 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Fondaparinux dosage: 7.5 Mg Everyday Sq.

6139954-4 | Anaemia, Clostridial Infection, Confusional State, Dialysis, Fall, Haemorrhage, Hypotension, International Normalised Ratio Decreased, Mental Disorder
Patient was taking Fondaparinux (View Usage). Patient had the following side effects: anaemia, clostridial infection, confusional state, dialysis (What is dialysis?), fall (What is fall?), haemorrhage, hypotension, international normalised ratio decreased, mental disorder on Mar 31, 2009 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 219.8 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Fondaparinux dosage: 10 Mg Every Day Sq. During the same period patient was treated with WARFARIN SODIUM (Various Mg Every Day Po) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5968215-9 | Beta Haemolytic Streptococcal Infection, Bloody Discharge, Incision Site Haematoma, Incision Site Infection, Opportunistic Infection, Wound Secretion
Adverse event was reported on Nov 21, 2008 by a Female patient taking Fondaparinux (View Usage) (Dosage: 1.5mg Per Day) . Location: FRANCE , 82 years of age, weighting 158.7 lb, After Fondaparinux was administered, patient had the following side effects: beta haemolytic streptococcal infection, bloody discharge, incision site haematoma, incision site infection, opportunistic infection, wound secretion. During the same period patient was treated with KARDEGIC (160mg Per Day) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5845239-3 | Beta Haemolytic Streptococcal Infection, Bloody Discharge, Haematoma, Opportunistic Infection, Wound Secretion
on Aug 08, 2008 Female patient from FRANCE , 82 years of age, weighting 158.7 lb, was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: beta haemolytic streptococcal infection, bloody discharge, haematoma, opportunistic infection, wound secretion. Fondaparinux dosage: 1.5mg Per Day. During the same period patient was treated with ASPIRIN (160mg Per Day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.


5836858-9 | Beta Haemolytic Streptococcal Infection, Opportunistic Infection, Wound Secretion
on Jul 31, 2008 Female patient from FRANCE , 82 years of age, weighting 158.7 lb, was treated with Fondaparinux (View Usage). Patient had the following side effects: beta haemolytic streptococcal infection, opportunistic infection, wound secretion. Fondaparinux dosage: 1.5mg Per Day. During the same period patient was treated with ASPIRIN (160mg Per Day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5711355-X | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia
Patient was taking Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia on Apr 11, 2008 from ITALY Additional patient health information: Female patient , 71 years of age, . Fondaparinux dosage: 2.5mg Four Times Per Day. During the same period patient was treated with NADROPARIN (.3mg Per Day) (View Nadroparin Review and Nadroparin Label ).

5644175-5 | Post Procedural Haematoma, Post Procedural Haemorrhage
Adverse event was reported on Feb 27, 2008 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5 Mg Every Day Sq) . Location: UNITED STATES , 74 years of age, Patient experienced the following unwanted or unexpected effects: post procedural haematoma, post procedural haemorrhage. Patient was hospitalized.

5568136-X | Haematuria
on Dec 18, 2007 Male patient from UNITED STATES , 86 years of age, was treated with Fondaparinux (View Usage). Patient had the following side effects: haematuria. Fondaparinux dosage: 2.5mg Every Day Sq. During the same period patient was treated with WARFARIN SODIUM (5mg Every Day Po) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5551126-0 | Balance Disorder, Malaise
on Dec 03, 2007 Male patient from FRANCE , 79 years of age, weighting 149.9 lb, was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: balance disorder, malaise. Fondaparinux dosage: 1.5mg Per Day. Patient was hospitalized and became disabled.

5551112-0 | Anaemia, Angina Pectoris, Electrocardiogram St Segment Depression
Patient was taking Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, angina pectoris, electrocardiogram st segment depression on Dec 03, 2007 from FRANCE Additional patient health information: Female patient , 82 years of age, weighting 143.3 lb, was diagnosed with anxiety (What is anxiety?) and. Fondaparinux dosage: 1.5mg Per Day. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZESTRIL (View Zestril Review and Zestril Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), AMLOR (View Amlor Review and Amlor Label ), AMARYL (View Amaryl Review and Amaryl Label ), VASTAREL (View Vastarel Review and Vastarel Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), CONTRAMAL (View Contramal Review and Contramal Label ). Patient was hospitalized.

5530484-7 | Haemorrhage
Adverse event was reported on Nov 27, 2007 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Every Day Po) . Location: UNITED STATES , 80 years of age, Patient had the following side effects: haemorrhage.

5066056-0 | Incorrect Dose Administered, Wound Haemorrhage
on Jul 31, 2006 Female patient from UNITED STATES , 41 years of age, was diagnosed with thrombosis prophylaxis and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: incorrect dose administered, wound haemorrhage. Fondaparinux dosage: 5 Mg Once Daily Sq. During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), PERCOCET (View Percocet Review and Percocet Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL SPIROS (View Albuterol Spiros Review and Albuterol Spiros Label ), ATROVEN (View Atroven Review and Atroven Label ), FOLATE (View Folate Review and Folate Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5055417-1 | Haematocrit Decreased, Hypotension, Post Procedural Complication
on Jul 17, 2006 Male patient from UNITED STATES , 80 years of age, weighting 156.3 lb, was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: haematocrit decreased, hypotension, post procedural complication. Fondaparinux dosage: 2.5mg Sq Daily. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CARTIA XT (View Cartia Xt Review and Cartia Xt Label ), FLOMAX (View Flomax Review and Flomax Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4954105-7 | Pharyngeal Oedema
Patient was taking Fondaparinux (View Usage). Patient had the following side effects: pharyngeal oedema on Mar 14, 2006 from SPAIN Additional patient health information: Male patient , 59 years of age, . Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ABCIXIMAB (View Abciximab Review and Abciximab Label ), IOPAMIDOL (View Iopamidol Review and Iopamidol Label ), MORPHINE (View Morphine Review and Morphine Label ).

4950514-0 | Cerebrovascular Accident
Adverse event was reported on Mar 10, 2006 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: MALAYSIA , 55 years of age, After Fondaparinux was administered, patient had the following side effects: cerebrovascular accident. During the same period patient was treated with STREPTASE (View Streptase Review and Streptase Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4949056-8 | Cardiac Procedure Complication, Coronary Artery Thrombosis
on Mar 10, 2006 Male patient from SPAIN , 59 years of age, was diagnosed with acute myocardial infarction and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac procedure complication, coronary artery thrombosis. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ABCIXIMAB (View Abciximab Review and Abciximab Label ).

4949055-6 | Cardiac Procedure Complication, Coronary Artery Thrombosis, Postoperative Thrombosis
on Mar 10, 2006 Female patient from GERMANY , 69 years of age, was diagnosed with acute myocardial infarction and was treated with Fondaparinux (View Usage). Patient had the following side effects: cardiac procedure complication, coronary artery thrombosis, postoperative thrombosis. Fondaparinux dosage: 2.5mg Per Day.

4947813-5 | Cardiac Tamponade, Myocardial Rupture, Pericardial Haemorrhage
Patient was taking Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: cardiac tamponade, myocardial rupture, pericardial haemorrhage on Mar 10, 2006 from RUSSIAN FEDERATION Additional patient health information: Female patient , 85 years of age, was diagnosed with acute myocardial infarction and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

4946577-9 | Cerebrovascular Accident
Adverse event was reported on Mar 09, 2006 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) . Location: INDIA , 67 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BETA BLOCKER (View Beta Blocker Review and Beta Blocker Label ), CALCIUM CHANNEL BLOCKER (View Calcium Channel Blocker Review and Calcium Channel Blocker Label ), ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ).

4946576-7 | Coronary Artery Thrombosis
on Mar 09, 2006 Male patient from SPAIN , 74 years of age, was treated with Fondaparinux (View Usage). Patient had the following side effects: coronary artery thrombosis. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with NITRATES (View Nitrates Review and Nitrates Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

4945473-0 | Coronary Artery Thrombosis, Electromechanical Dissociation
on Mar 09, 2006 Female patient from HUNGARY , 83 years of age, was diagnosed with acute myocardial infarction and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: coronary artery thrombosis, electromechanical dissociation. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BETALOC (View Betaloc Review and Betaloc Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), PETHIDINE (View Pethidine Review and Pethidine Label ).

4945449-3 | Dyspnoea, Hypotension, Rales, Renal Failure Acute
Patient was taking Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypotension, rales, renal failure acute on Mar 14, 2006 from BRAZIL Additional patient health information: Male patient , 93 years of age, . Fondaparinux dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), STATINS (View Statins Review and Statins Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

4943034-0 | Coronary Artery Thrombosis
Adverse event was reported on Feb 11, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: GERMANY , 62 years of age, weighting 229.3 lb, Patient had the following side effects: coronary artery thrombosis. During the same period patient was treated with ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

4943033-9 | Thrombosis In Device
on Jun 11, 2004 Male patient from CANADA , 62 years of age, weighting 130.1 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: thrombosis in device. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), PLAVIX (View Plavix Review and Plavix Label ).

4943032-7 | Catheter Related Complication
on Jun 24, 2004 Male patient from SWEDEN , 61 years of age, weighting 185.2 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TROMBYL (View Trombyl Review and Trombyl Label ).

4943031-5 | Catheter Related Complication
Patient was taking Fondaparinux (View Usage). Patient had the following side effects: catheter related complication on Jun 21, 2004 from ARGENTINA Additional patient health information: Male patient , 90 years of age, weighting 143.3 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

4943030-3 | Cardiac Arrest, Coronary Artery Thrombosis, Haematemesis, Myocardial Infarction, Ventricular Fibrillation
Adverse event was reported on Mar 08, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: UNITED KINGDOM , 66 years of age, weighting 198.4 lb, After Fondaparinux was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), coronary artery thrombosis, haematemesis, myocardial infarction, ventricular fibrillation. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), REOPRO (View Reopro Review and Reopro Label ). Patient was hospitalized.

4943029-7 | Catheter Related Complication
on May 25, 2004 Male patient from UNITED STATES , 62 years of age, weighting 205.0 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), IMDUR (View Imdur Review and Imdur Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PLAVIX (View Plavix Review and Plavix Label ), PRINIVIL (View Prinivil Review and Prinivil Label ).

4943027-3 | Catheter Related Complication, Retinal Artery Embolism
on Aug 10, 2004 Male patient from POLAND , 48 years of age, weighting 187.4 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient had the following side effects: catheter related complication, retinal artery embolism. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ).

4943026-1 | Catheter Related Complication
Patient was taking Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: catheter related complication on Apr 07, 2004 from FRANCE Additional patient health information: Female patient , 83 years of age, weighting 130.1 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with AGGRASTAT (View Aggrastat Review and Aggrastat Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MOLSIDOMINE (6mg Per Day) (View Molsidomine Review and Molsidomine Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), TIROFIBAN HYDROCHLORIDE (View Tirofiban Hydrochloride Review and Tirofiban Hydrochloride Label ).

4943025-X | Catheter Related Complication
Adverse event was reported on Jul 02, 2004 by a Female patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: POLAND , 66 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: catheter related complication. During the same period patient was treated with AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CILAZAPRIL (View Cilazapril Review and Cilazapril Label ), INSULIN (View Insulin Review and Insulin Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), NITRATE (View Nitrate Review and Nitrate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4943024-8 | Catheter Related Complication
on Jun 24, 2004 Male patient from UNITED STATES , 63 years of age, weighting 270.3 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient had the following side effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), COREG (12.5mg Per Day) (View Coreg Review and Coreg Label ), DIGOXIN (.125mg Per Day) (View Digoxin Review and Digoxin Label ), IMDUR (15mg Per Day) (View Imdur Review and Imdur Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), LASIX (80mg Per Day) (View Lasix Review and Lasix Label ), LIPITOR (20mg Per Day) (View Lipitor Review and Lipitor Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

4943023-6 | Catheter Related Complication
on Jun 25, 2004 Male patient from NETHERLANDS , 62 years of age, weighting 209.4 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with AGGRASTAT (View Aggrastat Review and Aggrastat Label ), ASCAL (View Ascal Review and Ascal Label ), DIOVAN (View Diovan Review and Diovan Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), SELOKEEN (View Selokeen Review and Selokeen Label ).

4943022-4 | Coronary Artery Thrombosis
Patient was taking Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery thrombosis on Apr 23, 2004 from ITALY Additional patient health information: Female patient , 63 years of age, weighting 154.3 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), NITRATES (View Nitrates Review and Nitrates Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (2.5mg Per Day) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

4943021-2 | Cholecystitis, Clostridial Infection, Graft Thrombosis, Multi-organ Failure, Post Procedural Haemorrhage
Adverse event was reported on Jan 15, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) . Location: SWEDEN , 68 years of age, weighting 185.2 lb, Patient had the following side effects: cholecystitis, clostridial infection, graft thrombosis, multi-organ failure, post procedural haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CYCLOKAPRON (View Cyclokapron Review and Cyclokapron Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low Molecular Weight Heparin Review and Low Molecular Weight Heparin Label ). Patient was hospitalized.

4943020-0 | Catheter Related Complication
on May 21, 2004 Male patient from CANADA , 81 years of age, weighting 185.2 lb, was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (50mg Per Day) (View Atenolol Review and Atenolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), INSULIN (View Insulin Review and Insulin Label ), LASIX (View Lasix Review and Lasix Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ).

4943019-4 | Catheter Related Complication
on Jun 04, 2004 Male patient from ARGENTINA , 49 years of age, weighting 180.8 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), NITRATES (View Nitrates Review and Nitrates Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4943018-2 | Catheter Related Complication
Patient was taking Fondaparinux (View Usage). Patient had the following side effects: catheter related complication on Jun 25, 2004 from POLAND Additional patient health information: Male patient , 71 years of age, weighting 231.5 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (75mg Per Day) (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (50mg Per Day) (View Metoprolol Review and Metoprolol Label ), TICLOPIDINE HCL (500mg Per Day) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ).

4943017-0 | Circulatory Collapse, Coronary Artery Thrombosis
Adverse event was reported on May 25, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: FINLAND , 73 years of age, weighting 176.4 lb, After Fondaparinux was administered, patient had the following side effects: circulatory collapse, coronary artery thrombosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (5mg Per Day) (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4943015-7 | Coronary Artery Dissection, Coronary Artery Thrombosis
on Jan 28, 2004 Male patient from CANADA , 61 years of age, weighting 220.5 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery dissection, coronary artery thrombosis. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with AGGRASTAT (View Aggrastat Review and Aggrastat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

4943014-5 | Catheter Related Complication
on Aug 03, 2004 Male patient from AUSTRALIA , 63 years of age, weighting 172.0 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient had the following side effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

4943013-3 | Catheter Related Complication, Thrombosis
Patient was taking Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: catheter related complication, thrombosis on Jun 17, 2004 from AUSTRALIA Additional patient health information: Male patient , 48 years of age, weighting 238.1 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (100mg Per Day) (View Metoprolol Review and Metoprolol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4943012-1 | Catheter Related Complication, Coronary Artery Thrombosis
Adverse event was reported on Apr 06, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: SPAIN , 77 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: catheter related complication, coronary artery thrombosis. During the same period patient was treated with ACOVIL (View Acovil Review and Acovil Label ), CARDYL (View Cardyl Review and Cardyl Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

4943011-X | Catheter Related Complication, Thrombosis
on Jun 11, 2004 Male patient from NETHERLANDS , 70 years of age, weighting 227.1 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient had the following side effects: catheter related complication, thrombosis. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with AGGRASTAT (View Aggrastat Review and Aggrastat Label ), ASCAL (View Ascal Review and Ascal Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PLAVIX (View Plavix Review and Plavix Label ), SELOKEEN (View Selokeen Review and Selokeen Label ).

4943010-8 | Pancytopenia
on Nov 11, 2003 Female patient from SPAIN , 69 years of age, weighting 158.7 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: pancytopenia. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4943009-1 | Catheter Related Complication
Patient was taking Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication on Apr 07, 2004 from SWEDEN Additional patient health information: Male patient , 73 years of age, weighting 202.8 lb, was diagnosed with acute coronary syndrome and. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4943008-X | Catheter Related Complication
Adverse event was reported on Jun 29, 2004 by a Male patient taking Fondaparinux (View Usage) (Dosage: 2.5mg Per Day) was diagnosed with acute coronary syndrome and. Location: UNITED STATES , 77 years of age, weighting 172.0 lb, Patient had the following side effects: catheter related complication. During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ASPIRIN (81mg Per Day) (View Aspirin Review and Aspirin Label ), CARVEDILOL (50mg Per Day) (View Carvedilol Review and Carvedilol Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), HUMAN INSULIN (View Human Insulin Review and Human Insulin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL (25mg Per Day) (View Metoprolol Review and Metoprolol Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

4943007-8 | Catheter Related Complication
on Jul 02, 2004 Female patient from POLAND , 66 years of age, weighting 116.8 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). After Fondaparinux was administered, patient had the following side effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), NITRATE (View Nitrate Review and Nitrate Label ), STATINS (View Statins Review and Statins Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ).

4943006-6 | Catheter Related Complication
on Jul 02, 2004 Male patient from GERMANY , 62 years of age, weighting 209.4 lb, was diagnosed with acute coronary syndrome and was treated with Fondaparinux (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication. Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMITRIPTYLIN (View Amitriptylin Review and Amitriptylin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN (1700mg Per Day) (View Metformin Review and Metformin Label ), METOPROLOL (95mg Per Day) (View Metoprolol Review and Metoprolol Label ).

4942993-X | Bradycardia, Cardiogenic Shock, Coronary Artery Thrombosis, Nausea, Respiratory Arrest
Patient was taking Fondaparinux (View Usage). Patient had the following side effects: bradycardia, cardiogenic shock, coronary artery thrombosis, nausea (What is nausea?), respiratory arrest on Mar 09, 2006 from ARGENTINA Additional patient health information: Female patient , 67 years of age, . Fondaparinux dosage: 2.5mg Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).